Coherus Oncology, Inc. (NASDAQ:CHRS) Sees Significant Decline in Short Interest
Coherus Oncology, Inc. (NASDAQ:CHRS – Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 12,452,177 shares, a decline of 46.6% from the September 30th total of 23,337,539 shares. Based on an average daily volume of 1,579,236 shares, […]
31 Oct 21:21 · The Markets Daily